Skip to main content

Injuries

2
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
1
Am Academy of Pediatrics print materialsPhase 21 trial
Active Trials
NCT02329340Completed175Est. Aug 2010
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
1
Am Academy of Pediatrics print materialsPhase 2
Verona Pharma
Verona PharmaUK - London
1 program
Maximal incremental running testN/A1 trial
Active Trials
NCT04103437Completed112Est. Dec 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesAm Academy of Pediatrics print materials
Verona PharmaMaximal incremental running test

Clinical Trials (2)

Total enrollment: 287 patients across 2 trials

NCT02329340Human BioSciencesAm Academy of Pediatrics print materials

Safety Skills Training: Parents of School-Aged Children

Start: Sep 2009Est. completion: Aug 2010175 patients
Phase 2Completed
NCT04103437Verona PharmaMaximal incremental running test

Evaluation of Harmonicity in Running Gait by the Use of Innovative Techniques of Video Analysis

Start: Nov 2018Est. completion: Dec 2019112 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.